Exploratory Factor Analysis (EFA) is a pivotal statistical approach that enables researchers to uncover latent structures in complex datasets, a process that is increasingly integral to higher ...
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve ...
SAN DIEGO — An analysis comparing patient-level data from two recent phase 3 trials demonstrated an approximately 40% reduction in the risk for non–small cell lung cancer (NSCLC) recurrence or death ...
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H AI-powered HER2 quantification continuous score (QCS) and tumor ...
Capivasertib (C) and fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Characterization and management of common adverse events (AEs) ...
Durvalumab consolidation therapy reduced the rate of extrathoracic metastases vs placebo and prolonged the time to progression or death due to any metastases in patients with limited-stage small-cell ...
The U S. Federal Reserve included a new facet of its annual stress test designed to explore "additional hypothetical risks" to the banking system. This year, the Fed studied the rapid repricing of ...
CAMO Software has launched a new version of its all-in-one multivariate data analysis (MVA) software, the Unscrambler X. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results